Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Aurobindo Pharma Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
524804
INE406A01037
335.4746309
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
AUROPHARMA
33.61
69533.33
EPS(TTM)
Face Value(
)
Div & Yield %:
35.31
1
0.38
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
10645.64
8457.00
11287.14
15823.68
13370.77
12257.89
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
10645.64
8457.00
11287.14
15823.68
13370.77
12257.89
Other Income
670.10
443.92
670.99
589.86
388.79
199.22
Stock Adjustments
116.23
263.95
-45.51
-2.99
238.67
289.80
Total Income
11431.97
9164.87
11912.62
16410.55
13998.23
12746.91
EXPENDITURE :
Raw Materials
5964.48
4755.95
5800.74
7241.83
6819.85
6469.55
Power & Fuel Cost
191.58
167.86
477.99
512.34
526.31
505.96
Employee Cost
980.56
890.53
1600.04
1735.42
1577.14
1362.77
Other Manufacturing Expenses
414.51
328.42
705.68
925.86
814.44
795.13
Selling & Administrative Expenses
822.21
939.38
1009.36
1069.84
938.36
786.90
Miscellaneous Expenses
164.49
148.96
249.13
215.57
235.47
218.09
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
8537.83
7231.10
9842.94
11700.86
10911.57
10138.40
Operating Profit
2894.14
1933.77
2069.68
4709.69
3086.66
2608.51
Interest
182.60
74.58
16.94
28.68
243.28
230.86
Gross Profit
2711.54
1859.19
2052.74
4681.01
2843.38
2377.65
Depreciation
254.58
243.26
415.26
488.00
473.33
413.03
Profit Before Tax
2456.96
1615.93
1637.48
4193.01
2370.05
1964.62
Tax
598.08
412.16
379.70
1043.34
492.28
378.56
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
-95.26
-23.34
-196.93
36.76
0.89
56.33
Reported Net Profit
1954.14
1227.11
1454.71
3112.91
1876.88
1529.73
Extraordinary Items
1.17
9.94
-81.27
-0.13
-1.90
-8.01
Adjusted Net Profit
1952.97
1217.17
1535.98
3113.04
1878.78
1537.74
Adjustment below Net Profit
-1.69
8.28
1.69
-6.42
-44.88
0.00
P & L Balance brought forward
16660.08
15864.14
14671.41
11799.30
10143.08
8790.74
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
263.66
439.45
263.67
234.38
175.78
160.34
P & L Balance carried down
18348.87
16660.08
15864.14
14671.41
11799.30
10160.13
Dividend
263.66
439.45
0.00
0.00
0.00
146.48
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
450.00
750.00
900.00
400.00
300.00
250.00
Dividend Per Share(Rs)
4.50
7.50
9.00
4.00
3.00
2.50
Earnings Per Share-Unit Curr
33.35
20.94
24.83
53.13
32.03
26.11
Earnings Per Share(Adj)-Unit Curr
33.35
20.94
24.83
53.13
32.03
26.11
Book Value-Unit Curr
336.62
307.80
292.15
271.80
222.78
193.73
Book Value(Adj)-Unit Curr
336.62
307.80
292.15
271.80
222.78
193.73